| 1 |
Ranibizumab for Diabetic Macular Edema
Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology
|
11 Feb 2012 |
1,625 |
| 2 |
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology
Open access |
22 May 2013 |
831 |
| 3 |
Intravitreal Aflibercept for Diabetic Macular Edema
Jean‐François Korobelnik et al. · Ophthalmology
Open access |
8 Jul 2014 |
822 |
| 4 |
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA
Open access |
13 Nov 2015 |
779 |
| 5 |
Intravitreal Aflibercept for Diabetic Macular Edema
David M. Brown et al. · Ophthalmology
|
18 Jul 2015 |
624 |
| 6 |
Intravitreal Aflibercept for Diabetic Macular Edema
Jeffrey S. Heier et al. · Ophthalmology
|
18 Sep 2016 |
432 |
| 7 |
Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab
Peter A. Campochiaro, Raafay Sophie, Joel A. Pearlman et al. · Ophthalmology
Open access |
7 Oct 2013 |
354 |
| 8 |
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh et al. · Ophthalmology
Open access |
Apr 2019 |
273 |
| 9 |
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion
Ingrid Ursula Scott, Paul VanVeldhuisen, Michael S. Ip et al. · JAMA
Open access |
11 May 2017 |
218 |
| 10 |
Change in Diabetic Retinopathy Through 2 Years
Susan B. Bressler, Danni Liu, Adam R. Glassman et al. · JAMA Ophthalmology
Open access |
27 Apr 2017 |
164 |
| 11 |
The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing
Jeffrey S. Heier, David S. Boyer, Quan Dong Nguyen et al. · Ophthalmology
|
Jun 2011 |
154 |
| 12 |
RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION
Joseph M. Googe, Alexander J. Brucker, Neil M. Bressler et al. · Retina
Open access |
10 Mar 2011 |
150 |
| 13 |
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K. Maturi, Adam R. Glassman, Kristin Josic et al. · JAMA Ophthalmology
Open access |
30 Mar 2021 |
140 |
| 14 |
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti–Vascular Endothelial Growth Factor Therapy
Susan B. Bressler, Isoken Odia, Maureen G. Maguire et al. · JAMA Ophthalmology
Open access |
24 Jan 2019 |
106 |
| 15 |
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Chirag D. Jhaveri, Adam R. Glassman, Frederick L. Ferris et al. · New England Journal of Medicine
Open access |
14 Jul 2022 |
90 |
| 16 |
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Dennis M. Marcus et al. · JAMA Ophthalmology
Open access480 authors |
19 Aug 2022 |
86 |
| 17 |
Monthly Versus As-Needed Ranibizumab Injections in Patients with Retinal Vein Occlusion
Peter A. Campochiaro, Charles C. Wykoff, Michael A. Singer et al. · Ophthalmology
|
21 Jul 2014 |
84 |
| 18 |
Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Paolo S. Silva et al. · JAMA Ophthalmology
Open access480 authors |
19 Aug 2022 |
82 |
| 19 |
23-GAUGE VITRECTOMY IN 100 EYES
McGregor N. Lott, Michael Manning, Jasleen Singh et al. · Retina
|
Oct 2008 |
78 |
| 20 |
Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema
Mark Barakat, Charles C. Wykoff, Víctor H. González et al. · Ophthalmology Retina
Open access |
20 Aug 2020 |
57 |
| 21 |
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose)
for the READ-3 Study Group, D V, Yasir J. Sepah et al. · Eye
Open access |
31 Jul 2015 |
44 |
| 22 |
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)
Judy E. Kim, Adam R. Glassman, Kristin Josic et al. · Ophthalmology Retina
Open access |
12 Oct 2021 |
40 |
| 23 |
DIFFUSE ANTERIOR RETINOBLASTOMA
Hans E. Grossniklaus, Ranjit S. Dhaliwal, Daniel F Martin · Retina
|
Mar 1998 |
36 |
| 24 |
Twenty-four–Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes – Protocol 3 with High Dose (READ-3) Study
Yasir Jamal Sepah et al. · Ophthalmology
|
6 Oct 2016 |
34 |
| 25 |
VITREAL PENETRATION OF ORAL MOXIFLOXACIN IN HUMANS
McGregor N. Lott, Jeffrey J. Fuller, Heather Hancock et al. · Retina
|
Mar 2008 |
34 |
| 26 |
Protective Effects of the Carotenoid Zeaxanthin in Experimental Nonalcoholic Steatohepatitis
Sherman M. Chamberlain, Joshua D. Hall, J. A. Patel et al. · Digestive Diseases and Sciences
|
7 May 2009 |
32 |
| 27 |
Hyperoxia Therapy of Pre-Proliferative Ischemic Retinopathy in a Mouse Model
Wenbo Zhang, Harumasa Yokota, Zhimin Xu et al. · Investigative Ophthalmology & Visual Science
Open access |
25 Jun 2011 |
31 |
| 28 |
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
Arshad M. Khanani, Peter A. Campochiaro, Jordan M. Graff et al. · JAMA Ophthalmology
Open access |
6 Mar 2025 |
25 |
| 29 |
A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy
Arshad M. Khanani, Raj K. Maturi, Nika Bagheri et al. · Ophthalmology Science
Open access |
11 Apr 2022 |
23 |
| 30 |
Loss of thioredoxin function in retinas of mice overexpressing amyloid β
Folami Lamoke, Guido Ripandelli, Scott J. Webster et al. · Free Radical Biology and Medicine
|
21 Apr 2012 |
22 |
| 31 |
MICROPERIMETRIC ASSESSMENT OF RETINAL SENSITIVITY IN EYES WITH DIABETIC MACULAR EDEMA FROM A PHASE 2 STUDY OF INTRAVITREAL AFLIBERCEPT
Víctor H. González, David S. Boyer, Ursula Margarethe Schmidt-Erfurth et al. · Retina
|
27 Jan 2015 |
19 |
| 32 |
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial
Mark Barakat, David M. Brown, Allen Hu et al. · Ophthalmology Science
Open access |
25 Jul 2024 |
18 |
| 33 |
INTRAVITREAL RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY IN NON-ASIAN PATIENTS
Dennis M. Marcus, Harinderjit Singh, McGregor N. Lott et al. · Retina
|
18 Sep 2012 |
18 |
| 34 |
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema
Susan B. Bressler et al. · JAMA Ophthalmology
Open access134 authors |
12 Sep 2024 |
17 |
| 35 |
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
Yasir Jamal Sepah et al. · Eye
Open access129 authors |
15 Apr 2024 |
16 |
| 36 |
Vitreal Penetration of Oral and Topical Moxifloxacin in Humans
Jeffrey J. Fuller, McGregor N. Lott, Nathanael M. Henson et al. · American Journal of Ophthalmology
|
24 Oct 2006 |
16 |
| 37 |
Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema
Charles C. Wykoff, Dennis M. Marcus, Edoardo Midena et al. · JAMA Ophthalmology
Open access |
22 Dec 2016 |
14 |
| 38 |
Optical coherence tomography angiography and Humphrey visual field in patients with obstructive sleep apnea
Arash M. Davanian, Lindsay Williamson, Caitlen Taylor et al. · Journal of Clinical Sleep Medicine
Open access |
9 May 2022 |
11 |
| 39 |
INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME
Brian W. Toussaint, John W. Kitchens, Dennis M. Marcus et al. · Retina
|
23 Mar 2017 |
10 |
| 40 |
Blepharochalasis: something to cry about
Richard J. Browning, April T. Sanchez, STEPHEN C. MULLINS et al. · Journal of Cutaneous Pathology
|
13 Oct 2016 |
10 |
| 41 |
High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population
Dennis M. Marcus, H. Singh, Chelsea Fechter et al. · Eye
Open access |
4 Sep 2015 |
8 |
| 42 |
Four-Year Safety of Pegaptanib Sodium in Neovascular Age-Related Macular Degeneration (AMD): Results of the V.I.S.I.O.N. Trial
Dennis M. Marcus · Investigative Ophthalmology & Visual Science
|
14 May 2008 |
8 |
| 43 |
Long-term Follow-up of Intravitreal Aflibercept Injection (IAI) for Neovascular Age-Related Macular Degeneration (nAMD) in an Open-Label Extension of the VIEW1 Study
Dennis M. Marcus · Investigative Ophthalmology & Visual Science
|
30 Apr 2014 |
6 |
| 44 |
Complications, Compliance, and 3-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage
Venkatkrish M. Kasetty, Davis C. Starnes, Nitish Sood et al. · Ophthalmic surgery, lasers & imaging retina
|
Feb 2023 |
3 |
| 45 |
Endolaserless Vitrectomy With Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASER LESS TRIAL)
Dennis M. Marcus, Harinderjit Singh, Davis C. Starnes et al. · Journal of VitreoRetinal Diseases
|
2 Apr 2018 |
3 |
| 46 |
Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA
Charles C. Wykoff, Diana V. Do, W. Lloyd Clark et al. · Ophthalmology Retina
Open access |
17 Oct 2024 |
2 |
| 47 |
Gastrointestinal and Nutritional Disorders
Ioana Scherbakova, Royce W. S. Chen, Dennis M. Marcus et al.
Book chapter |
2022 |
2 |
| 48 |
Vitreal Penetration of Oral Moxifloxacin in Humans
Jatinder Pal Singh, McGregor N. Lott, H. Singh et al. · Investigative Ophthalmology & Visual Science
|
10 May 2007 |
2 |
| 49 |
The Course of Response to Focal/Grid Photocoagulation for Diabetic Macular Edema
Dennis M. Marcus · Investigative Ophthalmology & Visual Science
|
28 Apr 2009 |
2 |
| 50 |
Visual Improvement After Pars Plana Vitrectomy and Membrane Peeling for Vitreoretinal Traction Associated With Combined Hamartoma of the Retina and Retinal Pigment Epithelium
Jay B. Stallman · Retina
|
Dec 2002 |
1 |